Android app Apple app link

Edgewise Therapeutics, Inc. (EWTX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$27.03
Day's range
$29.32

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
06/17/2026 Goldman Sachs Paul Choi $32.00 $33.95   -5.74%
06/02/2026 RBC Capital Leonid Timashev $48.00 $38.27   25.43%
06/01/2026 Raymond James Martin Auster $66.00 $40.26   63.93%
06/01/2026 Wedbush Laura Chico $52.00 $40.26   29.16%
03/10/2026 Raymond James Martin Auster $46.00 $29.67   55.04%
02/26/2026 Evercore ISI Cory Kasimov $45.00 $29.66   51.72%
02/26/2026 Stifel Nicolaus James Condulis $25.00 $29.83   -16.19%
12/05/2024 Truist Financial Srikripa Devarakonda $50.00 $31.57   58.38%
10/11/2024 Piper Sandler Yasmeen Rahimi $51.00 $30.46   67.46%
09/20/2024 RBC Capital Leonid Timashev $42.00 $29.50   42.37%
09/19/2024 Leerink Partners Joseph Schwartz $42.00 $29.50   42.37%
07/01/2024 Piper Sandler Yasmeen Rahimi $48.00 $18.01   166.52%

Edgewise Therapeutics Inc FAQ's

Edgewise Therapeutics Inc has been rated by research analysts at RBC Capital, Goldman Sachs, Leerink Partners, H.C. Wainwright, Raymond James, Wedbush in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.